Delray Beach, FL, April 30, 2025 (GLOBE NEWSWIRE) -- The global cell counting market, valued at US$10.82 billion in 2023, is forecasted to grow at a robust CAGR of 7.7%, reaching US$11.12 billion in ...
Blood cancers — including lymphoma, leukemia, and myeloma — are often challenging to treat. Traditional chemotherapy and radiation therapy can have limited efficacy and cause severe side effects, ...
Based on product, the cell counting market is segmented into consumables and instruments. The consumables segment is further divided into media, sera & reagents, assay kits, microplates, accessories, ...
Dublin, March 21, 2024 (GLOBE NEWSWIRE) -- The "Global Cell Counting Market: Analysis By Product, By Application, By End-User, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029 ...
According to the report, the global cell counting market generated $7.7 billion in 2022, and is anticipated to generate $16.3 billion by 2032, witnessing a CAGR of 7.7% from 2023 to 2032. What are ...
"Prominent players in the cell counting market are Danaher Corporation (US), Thermo Fisher Scientific (US), Beckton Dickinson and Company (US), and Agilent Technologies Inc. (US), among others." ...
Automated cell counting in body fluids is revolutionising diagnostic pathways by replacing traditional manual methods with robust, high-throughput platforms. This approach enhances accuracy and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback